Dropping Medicaid “Best Price” Would Not Reduce Litigation Against Companies, Boston Prosecutor Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharma manufacturers will have the same incentives to violate Medicaid rebate requirements even if they are supposed to be more straightforward than the “best price” system, U.S. Attorney’s Office White Collar Crime Section Chief Loucks predicts.